TP53 and cancer: On the other hand, compounds that deplete mutant p53 may not be as robust as those restoring the p53 activity; however, as mentioned in Section “Introduction,” survival and growth of cancer cells are frequently dependent on mutant p53 (oncogene addiction) (13, 14).